# Ethics Approval Application Template

**Application to**: [Ethics Committee Name]
**Organization**: NSW Users & AIDS Association (NUAA)
**Project Title**: [Name]
**Application Date**: [Date]
**Application ID**: [If applicable]

---

## SECTION 1: PROJECT SUMMARY

### 1.1 Project Title

[Full project title]

---

### 1.2 Plain Language Project Summary (250 words max)

[Describe the project in plain language - what you're doing, who with, why, and what you hope to achieve]

---

### 1.3 Project Duration

- **Start Date**: [Date]
- **End Date**: [Date]
- **Total Duration**: [Months/years]

---

### 1.4 Principal Investigator/Project Lead

**Name**: [Name]
**Position**: [Title]
**Organization**: NSW Users & AIDS Association (NUAA)
**Qualifications**: [Relevant qualifications]
**Email**: [Email]
**Phone**: [Phone]

**Ethics Training Completed**: [Yes/No - specify training]

---

### 1.5 Research Team

| Name   | Role              | Organization | Qualifications | Email  |
| ------ | ----------------- | ------------ | -------------- | ------ |
| [Name] | [Co-Investigator] | [Org]        | [Quals]        | [Email]|
| [Name] | [Peer Researcher] | NUAA         | [Quals + Lived Experience] | [Email]|
| [Name] | [Data Analyst]    | [Org]        | [Quals]        | [Email]|

---

## SECTION 2: BACKGROUND & JUSTIFICATION

### 2.1 Background

**The Issue**:

[What problem or need does this project address? Include relevant statistics, literature, and community voices]

**Why This Project**:

[Why is this project needed? What gap does it fill?]

**Evidence Base**:

[What research or evidence supports this approach?]

**References**:

1. [Reference 1]
2. [Reference 2]
3. [Reference 3]

---

### 2.2 About NUAA

NSW Users & AIDS Association (NUAA) is the state-wide peer-led organization representing the interests and rights of people who use illicit drugs in NSW. Established in [year], NUAA operates on harm reduction principles and prioritizes the health, dignity, and rights of our community.

**Organizational Expertise**:

- [Relevant experience with this population]
- [Track record of ethical research/programs]
- [Peer-led approach and consumer participation]

---

## SECTION 3: PROJECT DESIGN

### 3.1 Research Questions / Project Objectives

**Primary Research Question**: [Main question]

**Secondary Research Questions**:

1. [Question 1]
2. [Question 2]
3. [Question 3]

**OR Project Objectives** (if program evaluation):

1. [Objective 1]
2. [Objective 2]
3. [Objective 3]

---

### 3.2 Study Design & Methodology

**Study Type**: [e.g., Mixed methods program evaluation, Qualitative research, Survey research]

**Methods**:

1. **[Method 1 - e.g., Pre/post surveys]**
   - Description: [What will be measured]
   - Sample: [Who, how many]
   - Timing: [When]
   - Tool: [Specific instrument/questions]

2. **[Method 2 - e.g., Semi-structured interviews]**
   - Description: [What will be explored]
   - Sample: [Who, how many]
   - Timing: [When]
   - Tool: [Interview guide topics]

3. **[Method 3 - e.g., Focus groups]**
   - Description: [What will be discussed]
   - Sample: [Who, how many groups]
   - Timing: [When]
   - Tool: [Discussion guide]

---

### 3.3 Study Duration & Timeline

| Phase                    | Activities                        | Timeframe    |
| ------------------------ | --------------------------------- | ------------ |
| **Phase 1: Setup**       | Ethics approval, recruitment      | Months 1-2   |
| **Phase 2: Data Collection** | Surveys, interviews, focus groups | Months 3-6   |
| **Phase 3: Analysis**    | Data analysis, interpretation     | Months 7-8   |
| **Phase 4: Dissemination**| Reporting, publication            | Months 9-12  |

---

## SECTION 4: PARTICIPANTS

### 4.1 Target Population

**Who**: [Description of participants - demographics, characteristics]

**Inclusion Criteria**:

- [Criterion 1 - e.g., Age 18+]
- [Criterion 2 - e.g., Current or past drug use]
- [Criterion 3 - e.g., NSW resident]
- [Criterion 4 - e.g., Participated in program (if evaluation)]

**Exclusion Criteria**:

- [Criterion 1 - e.g., Under 18 without guardian consent]
- [Criterion 2 - e.g., Unable to provide informed consent]

**Justification for Inclusion/Exclusion Criteria**:

[Why these criteria are appropriate and necessary]

---

### 4.2 Sample Size

**Target Sample**:

- Surveys: [Number]
- Interviews: [Number]
- Focus groups: [Number of groups, participants per group]

**Sample Size Justification**:

[Why this number is appropriate - e.g., statistical power, saturation, feasibility]

---

### 4.3 Recruitment

**Recruitment Methods**:

- [Method 1 - e.g., Posters in NUAA office and partner services]
- [Method 2 - e.g., Social media (NUAA channels)]
- [Method 3 - e.g., Word of mouth/peer referral]
- [Method 4 - e.g., Direct invitation to program participants]

**Recruitment Materials**: [Attached - flyer, social media post, email invitation]

**Recruitment Process**:

1. [Potential participants see/receive recruitment materials]
2. [They contact project team via phone/email]
3. [Project team provides information sheet and answers questions]
4. [If interested, consent process initiated]

**Incentives for Participation**:

- Survey completion: $[Amount - e.g., $20 gift voucher]
- Interview: $[Amount - e.g., $50 gift voucher]
- Focus group: $[Amount - e.g., $50 gift voucher + catering]

**Justification for Incentives**:

[Why incentives are appropriate - value participants' time and expertise, reduce barriers to participation, standard practice in NUAA]

---

### 4.4 Vulnerable Populations

**This project involves**:

- ☐ People who use drugs (stigmatized, potentially vulnerable)
- ☐ Aboriginal and Torres Strait Islander peoples
- ☐ People living with HIV/hepatitis
- ☐ LGBTIQ+ people
- ☐ People experiencing homelessness
- ☐ People in custody/contact with justice system
- ☐ People with mental health challenges
- ☐ Other: [Specify]

**Vulnerability Considerations**:

[How the project acknowledges and addresses potential vulnerability]

**Protections for Vulnerable Participants**:

- **Informed consent**: Enhanced process (see Section 5)
- **Right to withdraw**: Emphasized, no penalty
- **Support available**: [Referrals, crisis support]
- **Harm minimization**: [Trauma-informed questions, safe environment]
- **Confidentiality**: Rigorous privacy protections
- **Cultural safety**: [Specific measures for cultural groups]

---

## SECTION 5: INFORMED CONSENT

### 5.1 Consent Process

**How Consent Will Be Obtained**:

- Written consent form provided
- Verbal explanation of project by trained staff
- Opportunity to ask questions
- Time to consider (no pressure to decide immediately)
- Copy of signed consent form provided to participant

**Who Will Seek Consent**: [Names/roles - trained project staff, peer researchers]

**When Consent Will Be Sought**: [Before any data collection]

**Language & Accessibility**:

- Plain language consent forms (no jargon)
- Available in [other languages if needed]
- Read aloud for those who prefer
- Large print/accessible formats available

---

### 5.2 Consent Form Content

**Participant Information Sheet includes**:

- ☐ Project title and purpose
- ☐ What participation involves (time, activities)
- ☐ Voluntary participation
- ☐ Right to withdraw anytime without penalty
- ☐ Risks and benefits
- ☐ Confidentiality and how data will be used
- ☐ Who will have access to data
- ☐ How findings will be shared
- ☐ Storage and destruction of data
- ☐ Contact details for questions/concerns
- ☐ Ethics committee contact for complaints

**Consent Form Attached**: [Yes - see attachment]

---

### 5.3 Ongoing Consent

- Consent is ongoing, not a one-time event
- Participants can withdraw at any time
- Participants can skip questions or decline activities
- Participants will be reminded of their rights throughout

---

### 5.4 Consent for Specific Uses

**Separate consent obtained for**:

- ☐ Audio/video recording (optional, not required for participation)
- ☐ Use of quotes in publications (anonymized)
- ☐ Case study/story sharing (identifying - requires explicit consent)
- ☐ Photography (identifying)

---

## SECTION 6: RISKS & BENEFITS

### 6.1 Potential Risks

**Risk 1: Psychological distress**

- **Description**: Questions may touch on sensitive topics (drug use, stigma, trauma)
- **Likelihood**: Low-Medium
- **Severity**: Low-Medium
- **Mitigation**:
  - Trauma-informed questions
  - Right to skip questions/stop participation
  - Trained, supportive interviewers (including peers)
  - Referral to support services if needed
  - Debrief after participation

**Risk 2: Privacy breach**

- **Description**: Potential for identifying information to be disclosed
- **Likelihood**: Low
- **Severity**: High
- **Mitigation**:
  - De-identification of data
  - Secure storage (encrypted digital, locked physical)
  - Access limited to research team
  - Confidentiality training for team
  - Reporting in aggregate only

**Risk 3: Social/legal risks**

- **Description**: Disclosure of drug use could theoretically have social/legal consequences
- **Likelihood**: Very Low
- **Severity**: Medium-High
- **Mitigation**:
  - Anonymity protected
  - Data stored securely without identifying links
  - Certificate of Confidentiality (if applicable)
  - Clear communication about limits of confidentiality

**Risk 4: Stigma or discrimination**

- **Description**: Participation in a project about drug use could be stigmatizing
- **Likelihood**: Low
- **Severity**: Low-Medium
- **Mitigation**:
  - Participation is confidential
  - Non-stigmatizing language throughout
  - Peer-led approach reduces stigma
  - Participants can choose when/where to participate

---

### 6.2 Benefits

**Individual Benefits**:

- Opportunity to contribute to knowledge and change
- Having voice heard and valued
- Connection with peer community
- Access to information/resources through participation
- Incentive payment (practical benefit)

**Community Benefits**:

- Evidence to advocate for better services and policies
- Reduced stigma through participation of people with lived experience
- Improved programs based on community feedback

**Sector Benefits**:

- Evidence base for harm reduction approaches
- Model for peer-led research/evaluation

---

### 6.3 Risk-Benefit Analysis

[Discussion of how risks are minimized and how benefits outweigh remaining risks]

---

## SECTION 7: CONFIDENTIALITY & DATA MANAGEMENT

### 7.1 Data Collection

**What Data Will Be Collected**:

- **Demographic data**: Age, gender, location (postcode), [other]
- **Survey responses**: [Scales, questions]
- **Interview data**: Audio recordings + transcripts
- **Focus group data**: Audio recordings + transcripts, facilitator notes
- **Administrative data**: Attendance, participation records

**No Collection of**:

- Names (except on consent forms, stored separately)
- Addresses (except postcode)
- Identifiable health information (unless specifically needed and consented)

---

### 7.2 De-Identification

**Process**:

- Participants assigned unique ID code (e.g., P001, P002)
- Consent forms (with names) stored separately from data
- All data files use ID codes only
- Transcripts de-identified (names, locations, identifying details removed)
- Master list (name-ID link) stored securely, accessible only to PI

**Reporting**:

- Aggregate data only
- No individual-level reporting
- Quotes anonymized
- Demographic details aggregated to prevent identification (e.g., "people aged 30-40" not "35-year-old")

---

### 7.3 Data Storage

**During Project**:

- **Digital data**: Encrypted files on password-protected NUAA server
- **Physical data**: Locked filing cabinet in NUAA office
- **Audio recordings**: Encrypted, deleted after transcription and verification

**Access**:

- Limited to named research team members
- Password-protected access
- Confidentiality agreements signed by all team

**After Project**:

- Data stored for [5 years] as per [institutional/funder requirements]
- Then securely destroyed (digital files deleted, physical files shredded)

---

### 7.4 Data Sharing

**No Data Sharing Except**:

- De-identified, aggregated findings in reports/publications
- De-identified data may be shared with research partners (if consented)
- Required by law (court order, mandatory reporting obligations)

**Participant Access**:

- Participants can request their own data
- Participants can request withdrawal of their data (until analysis begins)

---

### 7.5 Limits of Confidentiality

**Confidentiality will be broken if**:

- **Mandatory reporting**: Risk of harm to child or vulnerable person (legal obligation)
- **Imminent risk**: Participant or other person at immediate risk of serious harm
- **Court order**: Legally required to provide information

**Participants will be informed** of these limits in consent process.

---

## SECTION 8: CULTURAL SAFETY & ETHICAL RESEARCH PRACTICE

### 8.1 Harm Reduction Principles

This project is grounded in harm reduction:

- **Non-judgmental**: No moral judgment about drug use
- **Meeting people where they're at**: No prerequisites for participation
- **Evidence-based**: Using proven approaches
- **Respect for autonomy**: Participants' choices respected

---

### 8.2 Peer-Led Approach

**Peer Researchers**:

- People with lived experience of drug use employed as researchers
- Involved in: [Design, data collection, analysis, dissemination]
- Remuneration: $300/session or $[hourly rate]
- Training provided: Research ethics, interviewing skills, data management
- Supervision and support available

**Benefits of Peer-Led Approach**:

- Builds trust with participants
- Culturally appropriate and safe
- Reduces power imbalances
- Values lived experience expertise

---

### 8.3 Cultural Safety for Aboriginal & Torres Strait Islander Peoples

**If project involves Aboriginal & Torres Strait Islander participants**:

- **Consultation**: Guidance from Aboriginal & Torres Strait Islander advisors/reference group
- **Cultural protocols**: Respect for cultural protocols in recruitment, data collection, analysis
- **Data sovereignty**: Aboriginal & Torres Strait Islander peoples have control over their data
- **Reporting**: Aboriginal & Torres Strait Islander-specific findings reported separately (if numbers allow) and shared with community first
- **Benefit**: Project designed to benefit Aboriginal & Torres Strait Islander community

**Aboriginal & Torres Strait Islander Researcher**:

[Name, role if applicable]

---

### 8.4 LGBTIQ+ Inclusivity

- Gender and sexuality questions inclusive (multiple options, prefer not to say)
- Non-heteronormative language
- LGBTIQ+-specific considerations in analysis (if relevant)

---

### 8.5 Accessibility

- Venues physically accessible (wheelchair access)
- Alternative formats (large print, digital, audio)
- Plain language
- Language interpreters available if needed
- Flexible timing/locations to suit participants

---

## SECTION 9: DISSEMINATION

### 9.1 How Findings Will Be Shared

**With Participants**:

- Plain language summary of findings
- Community forum/presentation
- Opportunity for feedback

**With Funder/Stakeholders**:

- Formal evaluation report
- Presentations/meetings

**With Sector/Public**:

- Peer-reviewed publications
- Conference presentations
- Policy briefs
- NUAA website/newsletter

**With Academic Community**:

- Journal articles
- Conference presentations
- Thesis/dissertation (if applicable)

---

### 9.2 Authorship

**Research team members** (including peer researchers) will be co-authors on publications based on:

- Substantial contribution to design, data collection, analysis, or writing
- Approval of final version
- Accountability for the work

**Acknowledgments**:

- Participants
- Advisory group
- Funders
- Partner organizations

---

## SECTION 10: FUNDING & CONFLICTS OF INTEREST

### 10.1 Funding Source

**Funder**: [Funder name and amount]

**Funder Role**:

- Financial support only
- No role in study design, data collection, analysis, or reporting
- [OR: Describe any funder involvement]

---

### 10.2 Conflicts of Interest

**Do any research team members have conflicts of interest?**

[None declared / OR describe any conflicts and how they will be managed]

Examples of conflicts: Financial interest in outcome, personal relationships, dual roles

---

## SECTION 11: REFERENCES

1. [Reference 1 - relevant research]
2. [Reference 2 - methodology source]
3. [Reference 3 - evidence for approach]
4. [Add as needed]

---

## SECTION 12: ATTACHMENTS

Please find attached:

1. ☐ Participant Information Sheet
2. ☐ Consent Form
3. ☐ Recruitment Flyer/Materials
4. ☐ Survey Instrument
5. ☐ Interview Guide
6. ☐ Focus Group Discussion Guide
7. ☐ Research Team CVs
8. ☐ Letter of Support from NUAA
9. ☐ Letter of Support from Partner Organizations (if applicable)
10. ☐ Cultural Advice/Approval (if applicable)

---

## SECTION 13: DECLARATIONS

### 13.1 Principal Investigator Declaration

I, [Name], declare that:

- This application is accurate and complete
- The project will be conducted in accordance with:
  - National Statement on Ethical Conduct in Human Research (2007, updated 2023)
  - Privacy Act 1988
  - [Other relevant codes/guidelines]
- I will notify the ethics committee of:
  - Any adverse events
  - Any proposed changes to the project
  - Project completion
- I have appropriate qualifications and experience to lead this project
- I will ensure all research team members are trained in ethics

**Signature**: ____________________________

**Name**: [Name]
**Date**: [Date]

---

### 13.2 Organizational Approval

**NUAA Approval**:

This project has been approved by NUAA management/board:

**Signature**: ____________________________

**Name**: [Name, Title]
**Date**: [Date]

---

## FOR ETHICS COMMITTEE USE ONLY

**Application ID**: ______________________
**Date Received**: ______________________
**Reviewer**: ______________________
**Decision**: ☐ Approved ☐ Conditional Approval ☐ Revisions Required ☐ Not Approved
**Approval Date**: ______________________
**Ethics Approval Number**: ______________________
**Approval Valid Until**: ______________________

---

**This template ensures thorough ethical consideration of research/evaluation projects involving people who use drugs and other potentially vulnerable populations.**
